SATIVANOL

Anti-diabetic pharmaceuticals; Anti-epileptic pharmaceutical preparations; Anti-inflammatory preparations; Dermatological pharmaceutical products; Dietary supplements; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Nutritional supplements; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for treating respiratory diseases; Pharmaceutical antitussive-cold preparations; Preparation for the relief of pain; Probiotic supplements; Vitamin supplements; Anti-inflammatories; Anxiolytics